NO20055616L - Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentet - Google Patents
Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentetInfo
- Publication number
- NO20055616L NO20055616L NO20055616A NO20055616A NO20055616L NO 20055616 L NO20055616 L NO 20055616L NO 20055616 A NO20055616 A NO 20055616A NO 20055616 A NO20055616 A NO 20055616A NO 20055616 L NO20055616 L NO 20055616L
- Authority
- NO
- Norway
- Prior art keywords
- drug
- agent
- antimicrobial
- formulation
- against organisms
- Prior art date
Links
- 239000004599 antimicrobial Substances 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000002245 particle Substances 0.000 abstract 4
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 239000004094 surface-active agent Substances 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000007900 aqueous suspension Substances 0.000 abstract 1
- 238000002050 diffraction method Methods 0.000 abstract 1
- 239000002563 ionic surfactant Substances 0.000 abstract 1
- 239000002736 nonionic surfactant Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46635403P | 2003-04-29 | 2003-04-29 | |
| PCT/US2004/013268 WO2004096180A1 (en) | 2003-04-29 | 2004-04-29 | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20055616D0 NO20055616D0 (no) | 2005-11-28 |
| NO20055616L true NO20055616L (no) | 2006-01-25 |
Family
ID=33418369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055616A NO20055616L (no) | 2003-04-29 | 2005-11-28 | Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentet |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1617818A1 (https=) |
| JP (1) | JP2006525345A (https=) |
| KR (1) | KR20060015553A (https=) |
| CN (1) | CN1794975A (https=) |
| AU (1) | AU2004234003A1 (https=) |
| BR (1) | BRPI0409929A (https=) |
| CA (1) | CA2523151A1 (https=) |
| MX (1) | MXPA05011607A (https=) |
| NO (1) | NO20055616L (https=) |
| WO (1) | WO2004096180A1 (https=) |
| ZA (1) | ZA200508467B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100858508B1 (ko) | 2005-12-23 | 2008-09-12 | 주식회사 삼양사 | 아졸계 항진균제를 포함하는 조성물 및 그의 제조방법 |
| SG170047A1 (en) * | 2006-05-30 | 2011-04-29 | Elan Pharma Int Ltd | Nanoparticulate posaconazole formulations |
| FR2922107B1 (fr) * | 2007-10-10 | 2010-02-26 | Aventis Pharma Sa | Nouvelles compositions a base de taxoides |
| US20090238867A1 (en) * | 2007-12-13 | 2009-09-24 | Scott Jenkins | Nanoparticulate Anidulafungin Compositions and Methods for Making the Same |
| ES2476240T3 (es) * | 2010-12-30 | 2018-03-06 | Aktsionernoye Obshchestvo "Nauchnyi Tsentr Protivoinfektsionnyh Preparatov" | Agente antibacteriano para el tratamiento de enfermedades infecciosas de origen bacteriano |
| CN102085176A (zh) * | 2010-12-31 | 2011-06-08 | 江苏中丹制药有限公司 | 一种纳米级伊曲康唑外用制剂、其制备方法及其用途 |
| CN102106832A (zh) * | 2011-02-12 | 2011-06-29 | 华中师范大学 | 酮康唑纳米混悬剂冻干粉及其制备方法 |
| JP6962655B2 (ja) * | 2015-07-07 | 2021-11-05 | ライフラフト バイオサイエンシーズ，インコーポレイテッド | 低ナトリウムポロキサマー１８８製剤および使用方法 |
| CN111658601A (zh) * | 2020-06-12 | 2020-09-15 | 浙江普利药业有限公司 | 伏立康唑外用制剂及其制备方法 |
| IT202000030443A1 (it) * | 2020-12-10 | 2022-06-10 | Zambon Spa | Polvere inalabile comprendente voriconazolo in forma cristallina |
| WO2025023975A1 (en) * | 2023-07-27 | 2025-01-30 | Bard Peripheral Vascular, Inc. | Methods for the preparation of phospholipid bilayer carriers |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100635456B1 (ko) * | 1998-05-29 | 2006-10-18 | 스키에파마 캐나다 인코포레이티드 | 열보호화 마이크로입자 조성물 및 그의 말단의 스팀멸균방법 |
| AU7984200A (en) * | 1999-09-21 | 2001-04-24 | Skyepharma Canada Inc. | Surface modified particulate compositions of biologically active substances |
| US20030072807A1 (en) * | 2000-12-22 | 2003-04-17 | Wong Joseph Chung-Tak | Solid particulate antifungal compositions for pharmaceutical use |
| NZ526608A (en) * | 2000-12-22 | 2006-06-30 | Baxter Int | Method for preparing submicron particle suspensions |
| US7112340B2 (en) * | 2001-10-19 | 2006-09-26 | Baxter International Inc. | Compositions of and method for preparing stable particles in a frozen aqueous matrix |
-
2004
- 2004-04-29 EP EP04760446A patent/EP1617818A1/en not_active Withdrawn
- 2004-04-29 AU AU2004234003A patent/AU2004234003A1/en not_active Abandoned
- 2004-04-29 JP JP2006513447A patent/JP2006525345A/ja not_active Withdrawn
- 2004-04-29 BR BRPI0409929-0A patent/BRPI0409929A/pt not_active IP Right Cessation
- 2004-04-29 WO PCT/US2004/013268 patent/WO2004096180A1/en not_active Ceased
- 2004-04-29 MX MXPA05011607A patent/MXPA05011607A/es unknown
- 2004-04-29 KR KR1020057020567A patent/KR20060015553A/ko not_active Withdrawn
- 2004-04-29 CA CA002523151A patent/CA2523151A1/en not_active Abandoned
- 2004-04-29 CN CNA2004800116680A patent/CN1794975A/zh active Pending
-
2005
- 2005-10-19 ZA ZA200508467A patent/ZA200508467B/en unknown
- 2005-11-28 NO NO20055616A patent/NO20055616L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20060015553A (ko) | 2006-02-17 |
| NO20055616D0 (no) | 2005-11-28 |
| AU2004234003A1 (en) | 2004-11-11 |
| CA2523151A1 (en) | 2004-11-11 |
| JP2006525345A (ja) | 2006-11-09 |
| ZA200508467B (en) | 2006-09-27 |
| MXPA05011607A (es) | 2005-12-15 |
| CN1794975A (zh) | 2006-06-28 |
| BRPI0409929A (pt) | 2006-04-25 |
| EP1617818A1 (en) | 2006-01-25 |
| WO2004096180A1 (en) | 2004-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20055616L (no) | Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentet | |
| US10226048B2 (en) | Disinfecting detergent | |
| CA2351386A1 (en) | Highly concentrated aqueous glyphosate compositions | |
| ATE469633T1 (de) | Zahnpflegezusammensetzungen | |
| DE602005025083D1 (https=) | ||
| WO2007056424A3 (en) | Controlled-release emulsion compositions | |
| WO2003048288A3 (en) | Peroxygen compositions and methods for carpet or upholstery cleaning or sanitizing | |
| ATE399847T1 (de) | Reinigungsmittel vom typ der multiplen emulsion | |
| BR0317554B1 (pt) | Compostos peroxigenados revestidos com liberação controlada, um processo para preparação deles e uso dos mesmos | |
| CN102014618A (zh) | 微乳剂型杀菌组合物 | |
| TW200738283A (en) | Formulations of conjugated estrogens and bazedoxifene | |
| NO20030417D0 (no) | Benzofuranderivater og deres anvendelse som antibakterielle midler | |
| DE602004017895D1 (de) | Wässrige beschichtungszusammensetzungen | |
| MY151115A (en) | Disinfectant and/or bactericidal aqueous compositions | |
| DE50210284D1 (de) | Bioregulatorische wirkstoffkombination | |
| ITMI20022549A1 (it) | Composizione quaternaria comprendente come sostanza attiva la propolis. | |
| ATE333796T1 (de) | Flüssige antimikrobielle zusammensetzungen | |
| JP2006282629A (ja) | スプレー用組成物 | |
| AU2003286210A1 (en) | Smoke composition | |
| PT1896416E (pt) | Heterociclos substituídos, sua utilização como medicamentos e preparações farmacêuticas que os compreendem | |
| RU2007138389A (ru) | Паразитицидная водная суспензия | |
| DE69933463D1 (de) | Spray mit amphoterer zusammensetzung zur reduzierung von gerüchen | |
| WO2023111008A3 (en) | Fragranced aqueous composition comprising at least two surfactants, at least one fragrancing substance and at least one diol | |
| TW200507879A (en) | Powdery compositions and skin preparation containing the same for external use | |
| WO2005060361A3 (en) | Pharmaceutical formulations for itraconazole |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |